AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpure MV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimpure MV 1mg/500mg/0.3mg Tablet

Diabetic patients using the triple-combination medication, Glimpure MV (1mg/500mg/0.3mg), should understand its anti-diabetic properties. This formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Glimpure MV with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on your blood sugar response. Continuous use is crucial; abrupt cessation can elevate blood sugar, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight control, as directed by your doctor. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and have readily available glucose (sugary snacks or juice). Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections; weight gain is also possible. Glimpure MV is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment; pregnancy or breastfeeding necessitates medical consultation. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential.

Primary Ingredients of Glimpure MV 1mg/500mg/0.3mg Tablet

There is no text provided to rewrite.

Uses of Glimpure MV 1mg/500mg/0.3mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimpure MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimpure MV 1mg/500mg/0.3mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.

Common Side effects of Glimpure MV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimpure MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimpure MV 1mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption should occur on an empty stomach.

How Glimpure MV 1mg/500mg/0.3mg Tablet works:

Each Glimpure MV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure MV 1mg/500mg/0.3mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpure MV 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimpure MV 1mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Glimpure MV 1mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be avoided. Patients with severe kidney disease are strongly advised against using this medication. Medical consultation is recommended.

LiverLiverCAUTION

Patients with liver disease should use Glimpure MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver impairment, initiation with a low dose is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimpure MV 1mg/500mg/0.3mg Tablet :

Should you forget a Glimpure MV 1mg/500mg/0.3mg Tablet dose, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpure MV 1mg/500mg/0.3mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimpure MV 1mg/500mg/0.3mg Tablet

Glimpure MV 1mg/500mg/0.3mg tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus by improving blood glucose control in adults when combined with diet and exercise. Glimepiride enhances insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces postprandial glucose levels. This formulation is unsuitable for treating type 1 diabetes.
Taking Glimpure MV 1mg/500mg/0.3mg tablets may result in common adverse reactions such as low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, cephalalgia, dermatitis, and upper respiratory infections.
Patients with hypersensitivity to Glimpure MV 1mg/500mg/0.3mg Tablet constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glimpure MV 1mg/500mg/0.3mg Tablet is inadvisable. This combination may reduce blood glucose, potentially causing hypoglycemia, and heighten the risk of lactic acidosis.
Indeed, Glimpure MV 1mg/500mg/0.3mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Maintain this medication within its original, sealed packaging. Store as directed on the product label. Discard any remaining medicine. Prevent access by children, pets, and other individuals.
Glimpure MV 1mg/500mg/0.3...
158
MRP 192
17% off